Synthesis of Antiprotozoal 2-(4-Alkyloxyphenyl)-Imidazolines and Imidazoles and Their Evaluation on Leishmania mexicana and Trypanosoma cruzi

Int J Mol Sci. 2024 Mar 26;25(7):3673. doi: 10.3390/ijms25073673.

Abstract

Twenty 2-(4-alkyloxyphenyl)-imidazolines and 2-(4-alkyloxyphenyl)-imidazoles were synthesized, with the former being synthesized in two steps by using MW and ultrasonication energy, resulting in good to excellent yields. Imidazoles were obtained in moderate yields by oxidizing imidazolines with MnO2 and MW energy. In response to the urgent need to treat neglected tropical diseases, a set of 2-(4-alkyloxyphenyl)- imidazolines and imidazoles was tested in vitro on Leishmania mexicana and Trypanosoma cruzi. The leishmanicidal activity of ten compounds was evaluated, showing an IC50 < 10 µg/mL. Among these compounds, 27-31 were the most active, with IC50 values < 1 µg/mL (similar to the reference drugs). In the evaluation on epimastigotes of T. cruzi, only 30 and 36 reached an IC50 < 1 µg/mL, showing better inhibition than both reference drugs. However, compounds 29, 33, and 35 also demonstrated attractive trypanocidal activities, with IC50 values < 10 µg/mL, similar to the values for benznidazole and nifurtimox.

Keywords: Chagas disease; Leishmania mexicana; Trypanosoma cruzi; imidazole synthesis; imidazoline synthesis.

MeSH terms

  • Antiprotozoal Agents* / pharmacology
  • Chagas Disease*
  • Humans
  • Imidazoles / pharmacology
  • Imidazolines*
  • Leishmania mexicana*
  • Manganese Compounds
  • Oxides
  • Trypanosoma cruzi*

Substances

  • Imidazoles
  • Imidazolines
  • Manganese Compounds
  • Oxides
  • Antiprotozoal Agents

Grants and funding

This research was funded by CONAHCYT, grants 240808 and 255420, and IPN through grants 20231477 and 20230943.